Structure Therapeutics appoints Matthew Lang as chief...

2026-04-14 16:13:51 ET More on Structure Therapeutics Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety Moat Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target Structure Therapeutics rises on mid-stage data for oral GLP-1 Structure Therapeutics reports Q4 results Read the full article on Seeking Alpha For further details see: Structure Therapeutics appoints Matthew Lang as chief operating officer